MTVA - MetaVia Operating profit EBITDA

Brandmark of MetaVia Inc. (MTVA)

MetaVia Inc is developing AI-based neurotherapy to combat cognitive disorders. This EBITDA chart visualizes this process, where the 0.00 mark characterizes this parameter. Patent exclusivity will ensure future pricing power, while the focus on preclinical research shifts the struggle from sales to the realm of venture capital attraction.

MTVA (metaviatx.com) Operating profit EBITDA history from 11/23/2025 to 11/10/2026
Original product of MetaVia, Inc.

For MetaVia Inc (MTVA), which develops nerve tissue regeneration drugs with the potential for long-term patent income, operating profit before interest and taxes reflects the actual efficiency of cash flow generation from the core business. By analyzing the EBITDA snapshot, an investor assesses the company's ability to service debt under tight monetary policy, which confirms the fundamental resilience of the assets.

Competitors of MetaVia Inc (MTVA)

Company profit before taxes, interest and amortization BIIB (Biogen Idec)|Neurocrine Biosciences - Operating profit EBITDA|RGC - Operating profit EBITDA|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Viking Therapeutics Corp (VKTX) - Operating income before deduction of amortization|Operating profit EBITDA SUPN|Operating profit EBITDA catalystpharma.com (CPRX)|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|Operating income before deduction of amortization Amylyx Corp AMLX|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit before deduction of amortization CeriBell Inc (CBLL)|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Operating profit before deduction of amortization alector.com ALEC|Annexon, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization OMER (Omeros Corp)|NGNE: Operating profit before deduction of amortization|ACIU: Profit before payment of interest, taxes and amortization|VYGR: Operating profit EBITDA|Neumora Corp (NMRA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Scilex Holding Company|Operating profit before amortization TVGN (tevogen.com)|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Inhibikase - Operating profit before deduction of amortization|Operating profit EBITDA Cassava Pharma SAVA|ASRT - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization COYA (Coya Therapeutics, Inc.)|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Profit before payment of interest, taxes and amortization Acumen Pharma|Operating profit before deduction of amortization CervoMed Corporation (CRVO)|Operating profit EBITDA ATHE|CLNN - Profit before interest, taxes and amortization|PepGen - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization JUNS (Jupiter Neurosciences, Inc.)|Relmada - Operating profit EBITDA|ANVS - Operating profit EBITDA|GRCE (gracetx.com) - Operating profit before deduction of amortization|AIFF (fireflyneuro.com) - Profit before payment of interest, taxes and amortization|KLTO (ANEW Medical) - Operating profit EBITDA|NeuroSense Therapeutics, Ltd. (NRSN) - Operating income before deduction of amortization|Operating profit EBITDA RVPH|Operating profit EBITDA NeurAxis Inc (NRXS)|Helius Medical Technologies - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization PASG|Neuphoria - Operating profit EBITDA|Operating income before deduction of amortization Minerva Neurosciences Inc NERV|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ADXN|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Cyclerion (CYCN)|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit before deduction of amortization pasitheaclinics.com KTTA|Cortigent - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXI (Avenue Therapeutics Inc)|BCLI: Operating profit before deduction of amortization|CARA: Profit before payment of interest, taxes and amortization|CHRO: Operating profit EBITDA|Eliem Therapeutics Inc. (ELYM) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Operating profit before amortization LBPH (Longboard)|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.